The Significance of Monitoring Serum and Faecal Calprotectin in Healthy Dogs

The Significance of Monitoring Serum and Faecal Calprotectin in Healthy Dogs

The aim of this study was to monitor the concentrations of serum and faecal calprotectin in healthy dogs, determine confidence intervals, and observe its dependence on factors such as age. This study included 70 dogs representing 16 breeds, including samples collected from small and medium sized mix...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fialkovičová Maria, Benková Marta, Tóthová Csilla, Kejr Kristin Maria, Kunay Lukáš, Gomulcová Simona, Horňáková Ľubica, Karasová Martina, Bielik Bohumil, Takáčová Martina, Weissová Tatiana
Format:	Article
Language:	English
Published:	Sciendo 2024-12-01
Series:	Folia Veterinaria
Subjects:	calprotectin chronic inflammatory enteropathy dog
Online Access:	https://doi.org/10.2478/fv-2024-0039
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Faecal calprotectin concentration in children with coeliac disease
by: Anna Szaflarska-Popławska, et al.
Published: (2020-03-01)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
by: Walid Ellakany, et al.
Published: (2022-03-01)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
by: Hanan Galal Azouz, et al.
Published: (2021-12-01)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
by: Edyta Szymańska, et al.
Published: (2020-12-01)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
by: Ahmed F. Khalil, et al.
Published: (2020-11-01)

Diagnostic Possibilities of Determining the Level of Faecal Calprotectin in Clinical Practice
by: A. A. Sheptulin, et al.
Published: (2023-05-01)

Successful Treatment of Chronic Inflammatory Enteropathy in 2-Year-Old Yorkshire Terier. Case Report
by: Kunay Lukáš, et al.
Published: (2024-12-01)

Serum calprotectin in nonsegmental vitiligo: a possible marker of disease activity
by: Dalia A. Bassiouny, et al.
Published: (2025-01-01)

The concentration of calprotectin in the stools of children with diagnosed cystic fibrosis
by: Sabina Więcek, et al.
Published: (2016-03-01)

Estimation of salivary IL-6 and calprotectin in patients with ulcerative colitis
by: Fadhel A. Abdullah, et al.
Published: (2024-12-01)

The Role of Fecal Calprotectin in Investigating Pediatric Ulcerative Colitis
by: Fatih Ünal, et al.
Published: (2012-12-01)

Level of fecal neopterin and calprotectin in asymptomatic and symptomatic norovirus-infected children with malnutrition in Indonesia
by: Anisa Lailatul Fitria, et al.
Published: (2025-04-01)

Association of fecal calprotectin and lipocalin-2 with subclinical intestinal inflammation and disease activity in patients with axial spondyloarthritis
by: Eman Abdel Ghani Sayed, et al.
Published: (2025-12-01)

Effect of past extensive ulcers on fecal calprotectin in ulcerative colitis
by: Natsuki Ishida, et al.
Published: (2024-11-01)

Serum Calprotectin Level in Type 2 Diabetic Patients with and without Diabetic Peripheral Neuropathy: A Comparison Study
by: Israa Abdelmalik Salem, et al.
Published: (2024-12-01)

Clinical Comparison of OC-Sensor Pledia and Phadia 250 for Fecal Calprotectin Testing
by: Eunju Shin, et al.
Published: (2024-11-01)

Assessment of urine calprotectin and YKL-40 levels in urinary tract infection diagnosis in children under 2 years of age
by: Jędrzej Przekora, et al.
Published: (2024-11-01)

Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?
by: Büşra Tetik Dinçer, et al.
Published: (2024-12-01)

Developing and Externally Validating a Simple Index Based on the Nonlinear Relationship of Fecal Calprotectin and Long-Term Outcomes in Ulcerative Colitis
by: Zheng J, et al.
Published: (2024-12-01)

Activated CD27+PD-1+ CD8 T Cells and CD4 T Regulatory Cells Dominate the Tumor Microenvironment in Refractory Celiac Disease Type II
by: Tessa Dieckman, et al.
Published: (2025-01-01)

Elevated Calprotectin Levels Reveal Loss of Vascular Pattern and Atrophy of Villi in Ileum by Digital Chromoendoscopy and Magnification Colonoscopy in Patients with Spondyloarthritis Without Having Inflammatory Bowel Disease
by: Juliette De Avila, et al.
Published: (2024-11-01)

Case Report: Neonatal onset intractable diarrhea and hypoproteinemia due to intestinal malrotation and chronic midgut volvulus
by: Cuifang Zheng, et al.
Published: (2025-01-01)

Allergic enteritis in children
by: Mieczysława Czerwionka-Szaflarska, et al.
Published: (2017-01-01)

Correlation between fecal biomarkers and the presence of antineutrophil cytoplasmic antibodies with ulcerative colitis disease activity
by: Büşra Usta, et al.
Published: (2025-01-01)

Membranous nephropathy with eosinophilic gastroenteritis and protein-losing enteropathy： a case report and literature review
by: Ke Jia-er, et al.
Published: (2025-01-01)

Elderly Onset Primary Intestinal Lymphangiectasia—A Rare Case
by: Li‐Han Goh, et al.
Published: (2025-01-01)

Comparative Evaluation of Lipid Profile, C-Reactive Protein and Paraoxonase-1 Activity in Dogs with Inflammatory Protein-Losing Enteropathy and Healthy Dogs
by: Paola Gianella, et al.
Published: (2024-10-01)

Anthocyanin-Rich Extract Mitigates the Contribution of the Pathobiont Genus <i>Haemophilus</i> in Mild-to-Moderate Ulcerative Colitis Patients
by: Yannik Zobrist, et al.
Published: (2024-11-01)

Faecal calprotectin level: A potential biomarker for gastrointestinal graft versus host disease
by: Pallavi Wadhawan, et al.
Published: (2024-01-01)

Diabetic autonomic neuropathy of the gastrointestinal tract
by: Edwin Kuźnik, et al.
Published: (2020-06-01)

Enteropathy‐associated T‐cell lymphoma: A population‐based cohort study on incidence, treatment, and outcome in the Netherlands
by: Frederik O. Meeuwes, et al.
Published: (2024-12-01)

Prednisolone pharmacokinetics in dogs with protein‐losing enteropathy
by: Sara A. Jablonski, et al.
Published: (2025-01-01)

Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
by: Hyun Jung Lee, et al.
Published: (2024-11-01)

Effects of kefir addition on apparent digestibility of dry complete food, faecal characteristics, and blood parameters of healthy dogs
by: Oguzhan Kahraman, et al.
Published: (2024-12-01)

Can we predict hypoadrenocorticism in dogs with resting hypocortisolemia? A predictive model based on clinical, haematological, and biochemical variables
by: Nuno Sousa Santos, et al.
Published: (2024-12-01)

Clinical Characteristics and Prevalence of Celiac Disease in a Large Cohort of Type 1 Diabetes from Saudi Arabia
by: Mohammed Hakami, et al.
Published: (2024-11-01)

A unique case of protein-losing enteropathy as a complication of segmental arterial mediolysis
by: Nedaa Skeik, MD, FACC, FACP, FSVM, RPVI, et al.
Published: (2024-12-01)

Dual burden of infectious and chronic disease in low-resource U.S. communities: examining relationships between infection, adiposity, and inflammation
by: Theresa E. Gildner, et al.
Published: (2024-12-01)

Childhood developmental environment affects adult intestinal inflammation levels: preliminary evidence from older adults in the United States
by: Courtney Manthey, et al.
Published: (2024-12-01)

Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study
by: Sumaiah J. Alarfaj, et al.
Published: (2025-01-01)